About ProQolid

The success of Patient-Centered Outcomes (PCO) Research depends a great deal on the choice of appropriate Clinical Outcome Assessments (COAs). They should be selected by the domains they measure as well as the populations and the therapeutic areas they cover. Practical issues such as the availability of translations, copyrights, and access to COAs are also important considerations.

Mapi Research Trust created the PROQOLID™ database in 2002 as a tool to help you find the COA that is right for your needs and to provide a better knowledge and understanding of the relevant use of COAs, as well as to extend access to PCO resources for the scientific community. It has grown exponentially over the years, based on recommended sources such as the FDA (U.S. Food and Drug Administration), the EMA (European Medicines Agency), and the Research and Development scientific community.

Today, more than 2000 COAs are comprehensively described in the PROQOLID™ database, providing its users with two levels of information access:

• A free access level corresponding to basic information on the COA and available to all users at no charge
• A member access level available to users who subscribe toPROQOLID™. A username and password are required to access this advanced level of information.

PROQOLID™ mainly focuses on the original COAs developed: it provides descriptive information on COAs as well as descriptions of COAs related to the original (if relevant). The adequacy of the study methodology and the psychometric properties are not evaluated.

Free Access Level

The free access level presents basic information:

• Name of authors/developers
• Copyright notice
• Objective
• Therapeutic area
• Therapeutic indication
• Type of COA
• Original language(s) in which the COA was developed
• Bibliographic references used for the description of the COA in the database

Member Access Level

The member access level presents a greater degree of information on the COAs (if available):

• Contact information
• Conditions of use (including contact details of the person in charge of permission if the COA is not free of use)
• Review copy if available
• List of available translations as well as the related bibliographic references
• E-versions
• Characteristics: concepts of interests covered by the COA, number of items, population of intended use, recall period, time of completion, and administration mode
• Domains covered
• Scoring: response options, way of scoring, score direction
• Content validity documentation: information regarding the development of the COA
• Measurement properties: reliability, clinical validity, concurrent validity, and ability to detect change as measured in the original validation study of the instrument

In addition to these two levels, a tab named Related COA instrument facilitates browsing in PROQOLID™ if relevant.

COAs distributed by Mapi Research Trust

COAs distributed by Mapi Research Trust include the following additional information:

• Conditions of use of the COAs
• Access fees required for the use of the COAs
• Downloadable user agreements to be signed to get permission to use the COA
• Downloadable review copies of the instrument (which are for review purpose only)

View a PROQOLID page

Subscribe

Ensuring the information found in the PROQOLID™ database is not only accurate but also up to date, our staff works in close collaboration with the COA developers on a daily basis before publishing any information online.